What are the key takeaways from this The Doctor's Farmacy episode?

Key insights include: **Statin Efficacy Numbers:** Treating 83 people with statins for five years prevents one death in high-risk patients who already had heart attacks. For primary prevention in those without heart disease, 100 people taking statins for five years prevents one nonfatal heart attack without extending life by a single day.; **Trial Design Manipulation:** Pharmaceutical companies remove patients experiencing side effects during pre-randomization run-in phases before trials officially begin, then report results only from remaining participants. The Heart Protection Study eliminated one-third of volunteers for noncompliance before starting, systematically underreporting adverse effects to maximize drug sales.; **LDL Cholesterol Paradox:** Framingham data shows LDL below 250 mg/dL has no predictive value for coronary disease when corrected for triglycerides and HDL. Systematic review of 30 cholesterol-lowering drug trials found no consistent relationship between LDL reduction and cardiovascular event prevention, even in high-risk patients.

What did Dr. Aseem Malhotra and Dr. Aseem Malhotra discuss on The Doctor's Farmacy?

UK cardiologist Dr. Aseem Malhotra explains why he stopped prescribing statins after discovering commercial distortions in cholesterol research, revealing how LDL obsession masks insulin resistance as heart disease's true driver while pharmaceutical trials systematically underreport side effects. Key topics include: **Statin Efficacy Numbers:** Treating 83 people with statins for five years prevents one death in high-risk patients who already had heart attacks. For primary prevention in those without heart disease, 100 people taking statins for five years prevents one nonfatal heart attack without extending life by a single day.; **Trial Design Manipulation:** Pharmaceutical companies remove patients experiencing side effects during pre-randomization run-in phases before trials officially begin, then report results only from remaining participants. The Heart Protection Study eliminated one-third of volunteers for noncompliance before starting, systematically underreporting adverse effects to maximize drug sales..

How long is this episode of The Doctor's Farmacy?

This episode is 86 minutes long. SignalCast provides an AI-generated summary so you can get the key insights in about 3 minutes.

The Doctor's Farmacy

The Cardiologist Who Stopped Prescribing Statins Explains the Real Cause of Heart Attacks | Dr. Aseem Malhotra - ENCORE

December 24, 2025

86 min episode · 2 min read

Dr. Aseem Malhotra,Dr. Aseem Malhotra

Episode

86 min

Read time

2 min

Topics

Relationships, Leadership, Design & UX

AI-Generated Summary

Published Dec 25, 2025

Key Takeaways

✓Statin Efficacy Numbers: Treating 83 people with statins for five years prevents one death in high-risk patients who already had heart attacks. For primary prevention in those without heart disease, 100 people taking statins for five years prevents one nonfatal heart attack without extending life by a single day.
✓Trial Design Manipulation: Pharmaceutical companies remove patients experiencing side effects during pre-randomization run-in phases before trials officially begin, then report results only from remaining participants. The Heart Protection Study eliminated one-third of volunteers for noncompliance before starting, systematically underreporting adverse effects to maximize drug sales.
✓LDL Cholesterol Paradox: Framingham data shows LDL below 250 mg/dL has no predictive value for coronary disease when corrected for triglycerides and HDL. Systematic review of 30 cholesterol-lowering drug trials found no consistent relationship between LDL reduction and cardiovascular event prevention, even in high-risk patients.
✓Heart Attack Lipid Profile: Analysis of 231,000 heart attack patients across 541 hospitals revealed 75% had normal LDL under 130, while 50% had optimal levels under 100. The distinguishing factor was metabolic dysfunction with average HDL of 39 and triglycerides of 160, indicating insulin resistance drives disease.
✓Familial Hyperlipidemia Management: Among FH patients with genetically high cholesterol, 50% of men and 70% of women never develop premature heart disease. When corrected for insulin resistance through normal waist circumference and low insulin levels achieved via diet, FH patients' cardiovascular risk drops nearly to baseline population levels.

What It Covers

UK cardiologist Dr. Aseem Malhotra explains why he stopped prescribing statins after discovering commercial distortions in cholesterol research, revealing how LDL obsession masks insulin resistance as heart disease's true driver while pharmaceutical trials systematically underreport side effects.

Key Questions Answered

•Statin Efficacy Numbers: Treating 83 people with statins for five years prevents one death in high-risk patients who already had heart attacks. For primary prevention in those without heart disease, 100 people taking statins for five years prevents one nonfatal heart attack without extending life by a single day.
•Trial Design Manipulation: Pharmaceutical companies remove patients experiencing side effects during pre-randomization run-in phases before trials officially begin, then report results only from remaining participants. The Heart Protection Study eliminated one-third of volunteers for noncompliance before starting, systematically underreporting adverse effects to maximize drug sales.
•LDL Cholesterol Paradox: Framingham data shows LDL below 250 mg/dL has no predictive value for coronary disease when corrected for triglycerides and HDL. Systematic review of 30 cholesterol-lowering drug trials found no consistent relationship between LDL reduction and cardiovascular event prevention, even in high-risk patients.
•Heart Attack Lipid Profile: Analysis of 231,000 heart attack patients across 541 hospitals revealed 75% had normal LDL under 130, while 50% had optimal levels under 100. The distinguishing factor was metabolic dysfunction with average HDL of 39 and triglycerides of 160, indicating insulin resistance drives disease.
•Familial Hyperlipidemia Management: Among FH patients with genetically high cholesterol, 50% of men and 70% of women never develop premature heart disease. When corrected for insulin resistance through normal waist circumference and low insulin levels achieved via diet, FH patients' cardiovascular risk drops nearly to baseline population levels.

Notable Moment

Dr. Malhotra lost his NHS cardiology position after a newspaper labeled him a statin denier in a front-page campaign. The subsequent defamation lawsuit revealed the health editor coordinated with pharmaceutical-funded researchers to discredit doctors advocating informed consent, ultimately vindicating Malhotra's evidence-based concerns in court.

Know someone who'd find this useful?

Episode Transcript

So today, we're revisiting one of our most popular episodes of 2025. A conversation with esteemed UK cardiologist, doctor Asim Malhotra, a physician who went from being a top prescriber of statins to one of their most vocal and well informed critics. A stance that ultimately cost him his job and led to a major legal battle with the media. In this eye opening conversation, doctor Malhotra pulls back the curtain on the commercial distortions of scientific evidence that have shaped our understanding cholesterol and heart disease. He explains the statistical sleight of hand often used in clinical trials, the data pharmaceutical companies don't want the public to see, and why our decades long obsession with lowering LDL cholesterol may have done more harm than good. This conversation sparks so much engagement, reflection, and change within our community, and it deserves another spotlight. Whether you're revisiting the conversation or hearing it for the first time, we hope it brings you inspiration, insight, and nourishment in this holiday season. So thanks for being part of our podcast family. We'll be back in the new year with brand new episodes we can't wait to share with you. The fall into winter seasons is when our immune systems need the most support. It's colder, stress ramps up, and we're exposed to more challenges. That's why I turned to HTB Immune Energy Chews from Big Bold Health. They're made with one thousand milligrams of sprouted Himalayan tartary buckwheat, one of nature's richest sources of immune active polyphenols like quercetin and rutin. These compounds help support balance at the cellular level and may play a role in long term health. On top of that, every chew is fortified with vitamin c, vitamin d, magnesium, and zinc, the immune essentials most people don't get enough of. And the best part, they taste great with real cocoa and are easy to take on the go. This season, don't just react, strengthen your foundation. Try HTB Immune Energy Chews today. You can visit bigboldhealth.com and use code d r mark 20 for 20% off your first order. This time of year can be overwhelming. With holidays, work deadlines, even the shorter days can take a toll on your body and mind. Mind. That's where Sunlighten come in. Unlike traditional saunas, Sunlighten uses patented infrared technology to gently heat your body from the inside out. You can relax, detoxify, improve circulation, and even support your heart health all from the comfort of your home. It's not just about sweating. It's about creating a space to recharge, restore, and truly feel your best during a season that can be overwhelming. And right now, there's no better time to start. Set yourself up for a healthier, happier new year. Sunlighten makes it simple, safe, and incredibly soothing. Experience the sauna everyone's talking about. Your body and mind will thank you. Head over to sunlighten.com and save up to $1,400 on your purchase with code hymen. So welcome back to the podcast. …

Get the full transcript (18,519 words) + summary by email — free

One-time email with the complete transcript and AI summary of this episode. No account needed.

One email, no spam. We’ll also show you what SignalCast does.

Browse all The Doctor's Farmacy transcripts →